Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Urban-rural variations in quality-of-life in breast cancer survivors prescribed endocrine therapy

Lookup NU author(s): Dr Stephan Dombrowski, Professor Linda SharpORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2017 by the authors. Licensee MDPI, Basel, Switzerland. The number of breast cancer survivors has increased as a result of rising incidence and increased survival. Research has revealed significant urban-rural variation in clinical aspects of breast cancer but evidence in the area of survivorship is limited. We aimed to investigate whether quality of life (QoL) and treatment-related symptoms vary between urban and rural breast cancer survivors prescribed endocrine therapy. Women with a diagnosis of stages I-III breast cancer prescribed endocrine therapy were identified from the National Cancer Registry Ireland and invited to complete a postal survey (N = 1606; response rate = 66%). A composite measure of urban-rural classification was created using settlement size, population density and proximity to treatment hospital. QoL was measured using the Functional Assessment of Cancer Therapy (FACT-G) and an endocrine subscale. The association between urban-rural residence/status and QoL and endocrine symptoms was assessed using linear regression with adjustment for socio-demographic and clinical covariates. In multivariable analysis, rural survivors had a statistically significant higher overall QoL (β = 3.81, standard error (SE) 1.30, p < 0.01), emotional QoL (β = 0.70, SE 0.21, p < 0.01) and experienced a lower symptom burden (β = 1.76, SE 0.65, p < 0.01) than urban survivors. QoL in breast cancer survivors is not simply about proximity and access to healthcare services but may include individual and community level psychosocial factors.


Publication metadata

Author(s): Cahir C, Thomas AA, Dombrowski SU, Bennett K, Sharp L

Publication type: Article

Publication status: Published

Journal: International Journal of Environmental Research and Public Health

Year: 2017

Volume: 14

Issue: 4

Online publication date: 07/04/2017

Acceptance date: 05/04/2017

Date deposited: 25/04/2017

ISSN (print): 1661-7827

ISSN (electronic): 1660-4601

Publisher: MDPI AG

URL: https://doi.org/10.3390/ijerph14040394

DOI: 10.3390/ijerph14040394


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
ICE-2011-9
RL-2015-1579

Share